Market closedNon-fractional

Oramed Pharmaceuticals/ORMP

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Oramed Pharmaceuticals

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Ticker

ORMP

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

New York, United States

Employees

-

ORMP Metrics

BasicAdvanced
$104M
Market cap
9.94
P/E ratio
$0.26
EPS
1.86
Beta
-
Dividend rate
$104M
1.86
5.278
5.263
0.164
19.647
-5.14%
-4.65%
6.48%
9.941
153.883
0.62
0.62
-16.518
-75.06%
-134.31%

What the Analysts think about ORMP

Analyst Ratings

Majority rating from 2 analysts.
Hold

ORMP Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
$1.5M
-88.72%
Profit margin
0.00%
NaN%

ORMP Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 100.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.03
-$0.08
$0.33
$0.04
-
Expected
-$0.10
-$0.09
-$0.12
$0.02
-$0.02
Surprise
-70.00%
-5.88%
-375.00%
100.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Oramed Pharmaceuticals stock?

Oramed Pharmaceuticals (ORMP) has a market cap of $104M as of July 06, 2024.

What is the P/E ratio for Oramed Pharmaceuticals stock?

The price to earnings (P/E) ratio for Oramed Pharmaceuticals (ORMP) stock is 9.94 as of July 06, 2024.

Does Oramed Pharmaceuticals stock pay dividends?

No, Oramed Pharmaceuticals (ORMP) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Oramed Pharmaceuticals dividend payment date?

Oramed Pharmaceuticals (ORMP) stock does not pay dividends to its shareholders.

What is the beta indicator for Oramed Pharmaceuticals?

Oramed Pharmaceuticals (ORMP) has a beta rating of 1.86. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Oramed Pharmaceuticals stock

Buy or sell Oramed Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing